Illicit opioid adulterant trends in patients presenting with acute opioid overdose
Journal of Analytical Toxicology · 23.05.2026 · 50 (4)
DOI: 10.1093/jat/bkag006 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Analytical Toxicology, online erschienen am 19.02.2026. Verfasst von Michael Levine und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Division of Medical Toxicology, University of California, Los Angeles, Los Angeles, CA 90024, United States. Hauptthemen laut MEDLINE: Drug Contamination, Opiate Overdose, Analgesics, Opioid, Illicit Drugs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Institute on Drug Abuse of the National Institutes of Health.
Abstract (Originalsprache)
Clandestine fentanyl manufacturing oftentimes introduces adulterants and contaminants. This article aims to evaluate trends in adulterants from a cohort of patients presenting to the emergency department (ED) with illicit opioid overdose across the United States. The Fentalog Study group is a multicenter toxicology study group which evaluated ED patients with suspected opioid overdose at 10 medical centers across the United States between 21 September 2020 through 5 February 2024. Comprehensive qualitative toxicology testing was performed on residual serum specimens. Study sites were divided into three geographic regions: West (California, Oregon, Colorado), Midwest (Missouri, Michigan), and East (New York, New Jersey, Pennsylvania, Georgia). Illicit opioids were defined as fentanyl and fentanyl analogs, heroin or its metabolites, and/or novel potent opioids such as nitazenes. 1295 patients with confirmed illicit opioid overdose were included. Males accounted for the majority (73.7%) of patients. The median age was 39 (IQR: 31–54) years. Adulterants were detected in 745 (57.5%) patients. Quinine was the most abundantly encountered adulterant (433; 33.4%). Antihistamines were the most frequently detected class of adulterants (19.6%). There were significant differences in adulterants detected across the three time periods, with notable decreases in adulterants from time-period 1 (79.5%) to time-period 3 (41.7%; P < .001). Adulterants were found in 84 (27.0%) of patients that presented to a hospital in the Western United States, compared with 181 (24.3%) in the Midwest, and 480 (64.4%) of patients in the East (P < .001). Patients with concurrent cocaine were more likely having an adulterant present than those without cocaine present (OR 1.23; 95% CI 1.15–1.31). In contrast, patients with illicit opioids and concurrent methamphetamine were less likely to have adulterants present (OR 0.89; 95% CI 0.84–0.95). Adulteration of illicit opioids was more likely in the Eastern United States and for those with concurrent cocaine and opioid exposures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Division of Medical Toxicology, University of California, Los Angeles, Los Angeles, CA 90024, United States.
- American College of Medical Toxicology, Phoenix, AZ 85028, United States.
- Department of Emergency Medicine. Denver Health and Hospital Authority, Denver, CO 80045, United States.
- NYC Health + Hospitals/Elmhurst; Center for Research on Emerging Substances, Poisoning, Overdose, and New Discoveries (RESPOND), Icahn School of Medicine at Mount Sinai, New York, NY 11373, United States.
- University of Colorado School of Medicine, Aurora, CO 80045, United States.
- Rutgers New Jersey Medical School, Newark, NJ 07103, United States.
ORCID-Profile: Michael Levine, Alex Krotulski
Förderung
- National Institute on Drug Abuse of the National Institutes of Health
Zitieren
APA
Levine, M., Culbreth, R., Buchanan, J., Schwarz, E., Love, J., Brent, J., Meaden, C. W., Judge, B., Aldy, K., Hendrickson, R., Hughes, A., Krotulski, A., Logan, B., Shulman, J., Carpenter, J. E., Wax, P., Maducci, A. M., Calello, D. P., Campleman, S., …, & Toxicology Investigators Consortium (ToxIC) Fentalog Study Group (2026). Illicit opioid adulterant trends in patients presenting with acute opioid overdose. Journal of Analytical Toxicology, 50(4). https://doi.org/10.1093/jat/bkag006
Vancouver
Levine M, Culbreth R, Buchanan J, Schwarz E, Love J, Brent J, et al. Illicit opioid adulterant trends in patients presenting with acute opioid overdose. Journal of Analytical Toxicology. 2026;50(4). doi:10.1093/jat/bkag006
BibTeX
@article{Levine2026,
author = {Levine, Michael and Culbreth, Rachel and Buchanan, Jeannie and Schwarz, Evan and Love, Jennifer and Brent, Jeffrey and Meaden, Christopher W and Judge, Bryan and Aldy, Kim and Hendrickson, Rob and Hughes, Adrianne and Krotulski, Alex and Logan, Barry and Shulman, Joshua and Carpenter, Joseph E and Wax, Paul and Maducci, Alexandra M and Calello, Diane P and Campleman, Sharan and Manini, Alex F and Toxicology Investigators Consortium (ToxIC) Fentalog Study Group, Toxicology Investigators Consortium (ToxIC) Fentalog Study Group},
title = {Illicit opioid adulterant trends in patients presenting with acute opioid overdose},
journal = {Journal of Analytical Toxicology},
year = {2026},
volume = {50},
number = {4},
doi = {10.1093/jat/bkag006}
}
EUVIMED